Chelsea C. Pinnix

Dr. Chelsea C. Pinnix serves as Professor and Residency Program Director in the Department of Radiation Oncology at The University of Texas MD Anderson Cancer Center, where she joined the faculty in July 2012 after completing her combined MD/PhD program at the University of Pennsylvania and residency training at MD Anderson. Her clinical expertise focuses on radiation therapy for lymphoma patients within one of the world's leading cancer treatment institutions.

Dr. Pinnix's educational journey includes:

• Combined MD/PhD program at the University of Pennsylvania
• Residency training in Radiation Oncology at MD Anderson Cancer Center

Her research program centers on optimizing radiation therapy for lymphoma patients, with primary emphasis on minimizing normal tissue toxicity to improve long-term outcomes—particularly critical for young patients—and developing innovative strategies for aggressive/refractory lymphoma cases. She actively investigates the mechanisms behind synergistic chemotherapy-radiation approaches and technical advancements to reduce treatment-related morbidity while enhancing therapeutic efficacy.

As Residency Program Director, Dr. Pinnix oversees the comprehensive training of future radiation oncologists through MD Anderson's clinical education framework. While her research program contributes to advancing standard-of-care protocols, specific grant details remain unlisted in the provided materials.